Chemoinformaics analysis of Nonadecane
Molecular Weight | 268.529 | nRot | 16 |
Heavy Atom Molecular Weight | 228.209 | nRig | 0 |
Exact Molecular Weight | 268.313 | nRing | 0 |
Solubility: LogS | -7.327 | nHRing | 0 |
Solubility: LogP | 9.64 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 58.4017 |
nHD | 0 | BPOL | 40.1283 |
QED | 0.252 |
Synth | 1.068 |
Natural Product Likeliness | 0.129 |
NR-PPAR-gamma | 0.075 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.92 |
MDCK | 0.00000671 |
BBB | 0.049 |
PPB | 0.984199 |
VDSS | 4.189 |
FU | 0.013967 |
CYP1A2-inh | 0.137 |
CYP1A2-sub | 0.173 |
CYP2c19-inh | 0.286 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0.07 |
CYP2c9-sub | 0.956 |
CYP2d6-inh | 0.269 |
CYP2d6-sub | 0.043 |
CYP3a4-inh | 0.182 |
CYP3a4-sub | 0.034 |
CL | 4.467 |
T12 | 0.04 |
hERG | 0.279 |
Ames | 0.007 |
ROA | 0.028 |
SkinSen | 0.96 |
Carcinogencity | 0.029 |
EI | 0.933 |
Respiratory | 0.443 |
NR-Aromatase | 0.066 |
Antiviral | Yes |
Prediction | 0.563978 |